Medical Tourism Facilitator Tax in the UAE: The 2026 Guide

A medical tourism facilitator connects overseas patients with UAE hospitals and clinics, earning facilitation fees, coordination charges and sometimes markups on treatment packages. The tax picture splits in two: the facilitator's own fees are standard-rated services at 5% VAT, while the underlying medical treatment follows healthcare VAT rules that Cabinet Decision No. 149 of 2026 rewrote with effect from 1 October 2026.

The critical discipline is not quoting treatment VAT rates you cannot defend. The scope of qualifying treatment under CD 149/2026 is subject to further Cabinet/FTA clarification — CD 149/2026 leaves the medical-product list to a future Cabinet Decision. Facilitators who hard-code a rate into patient packages absorb the difference if the FTA disagrees — flag the uncertainty in writing instead.

Facilitation, case management, translation coordination, travel arrangement and second-opinion packaging are standard-rated services at 5% VAT where supplied in the UAE. The fee is taxable even when the underlying treatment has a different VAT treatment — the two supplies are legally distinct.

Invoice the facilitation fee separately from the hospital's treatment bill. Bundling them into one package price muddies both VAT analyses and leaves the patient unable to see what was charged for what — which is also a consumer-protection problem under health advertising rules.

Cabinet Decision No. 149 of 2026 rewrote the VAT treatment of healthcare services with effect from 1 October 2026. What it did not do — as of the FTA guidance available — is settle every boundary question: which treatments qualify, how mixed cosmetic-therapeutic procedures are treated, and how the rules apply to packages sold to non-resident patients.

The honest position for a facilitator: describe the treatment VAT as subject to further Cabinet/FTA clarification — CD 149/2026 leaves the medical-product list to a future Cabinet Decision in patient quotations, and build a contractual mechanism (a VAT-adjustment clause) for packages priced before the position is confirmed. Quoting a definitive rate now is the sector's biggest avoidable risk.

Registration is mandatory at AED 375,000 of taxable supplies with 30 days to apply and an AED 10,000 late penalty. Facilitation fees count in full toward the threshold — and where the facilitator acts as principal on packages, the package value may count too, which accelerates crossing dramatically.

Voluntary registration at AED 187,500 recovers VAT on office setup, marketing and systems early. Most facilitators should register at the voluntary threshold rather than waiting.

A pure agent discloses the hospital as the supplier, passes the treatment consideration through, and accounts for VAT only on its own commission or fee. A principal buys treatment capacity and resells packages in its own name — making its own supply with its own VAT analysis and invoicing obligations.

The contracts decide, not the marketing. If your terms say you "arrange" treatment but your invoices charge for the "package," you are inviting recharacterisation. Align the contracts, the invoices and the website copy — then apply the VAT treatment that follows.

Corporate tax is 0% on the first AED 375,000 of taxable profit and 9% above. Deductible costs include staff wages, office rent, marketing, travel and systems. Referral commissions paid to overseas agents are deductible with proper agreements and invoices — undocumented commissions are routinely disallowed.

Small Business Relief is available where revenue is AED 3 million or less: elect it in the return for tax periods ending on or before 31 December 2029. Registration and filing remain mandatory.

UAE domestic withholding tax is 0%: overseas patients pay your invoices in full, and commissions you pay to overseas referrers carry no UAE withholding. The VAT reverse charge may still apply to imported services used in the UAE — a VAT-registered facilitator self-accounts 5% on services bought from overseas suppliers.

Hospital referral commissions received from UAE hospitals are part of your taxable supplies: include them in the threshold test and charge VAT on them when registered. Document every referral fee with an agreement and invoice.

Healthcare advertising in the UAE is restricted — DHA and MOHAP rules limit claims about treatments, outcomes and practitioner credentials. Marketing spend is deductible for corporate tax, but fines for non-compliant advertising are not. Clear campaigns against the regulator's rules before spending.

Patient-data handling also has a compliance cost: health data is sensitive under UAE data-protection rules, and the systems to protect it are deductible business expenditure.

A facilitator earns AED 50,000 a month in coordination fees — AED 600,000 a year. Output VAT: AED 600,000 × 5% = AED 30,000. Input VAT on office, marketing and systems: AED 12,000. Net VAT payable: AED 18,000.

Corporate tax: revenue AED 600,000 minus wages AED 240,000, marketing AED 100,000, office and systems AED 80,000 — taxable profit AED 180,000, below the AED 375,000 threshold, so corporate tax is nil; Small Business Relief would in any case apply through 2029.

Issue tax invoices with TRN for every fee, numbered sequentially, with agency-vs-principal status stated. E-invoicing is coming to the UAE; a services business with contract-based billing adapts readily. File VAT returns each period and pay on time.

Keep seven years of records: client contracts, hospital agreements, referral-fee documentation, invoices, proof of any exported services and payroll files.

The recurring errors: quoting treatment VAT rates while CD 149/2026 scope is unconfirmed; acting as principal while invoicing as agent; missing the VAT threshold on fee income; paying referral commissions without agreements; and non-compliant health advertising that draws non-deductible fines.

The through-line is contracts: get the agency/principal position, the VAT-adjustment clause and the referral terms in writing before the first patient arrives.

A medical tourism facilitator in the UAE is a 5%-VAT services business sitting next to a healthcare VAT regime in transition: charge VAT on your fees, flag the CD 149/2026 treatment-scope uncertainty in every patient quotation, choose the agency or principal model deliberately, and use Small Business Relief while it lasts through 2029.

Before taking the first booking: align contracts, invoices and website copy on the agency question, and insert a VAT-adjustment clause in package pricing. Those two steps carry most of the sector's tax risk.

Cabinet Decision No. 149 of 2026 rewrote healthcare VAT with effect from 1 October 2026, and the qualifying-treatment scope remains subject to further Cabinet/FTA clarification — CD 149/2026 leaves the medical-product list to a future Cabinet Decision. For a facilitator quoting package prices to international patients, this creates a live commercial risk: a package priced with an assumed VAT treatment may need repricing when the FTA clarifies.

The professional response has three parts. First, never quote a treatment VAT rate as fact — quote the package price with a written caveat that the VAT treatment of the medical component is subject to further Cabinet/FTA clarification — CD 149/2026 leaves the medical-product list to a future Cabinet Decision. Second, build a price-adjustment clause into patient agreements and provider contracts, so a clarification does not come out of the facilitator's margin. Third, keep the facilitator's own commission invoicing entirely separate from the treatment VAT question — the commission is 5% regardless.

When the FTA clarifies, update every price list, website treatment page and patient quotation template the same day. Stale quotes are disputes waiting to happen.

Medical-travel bookings typically involve deposits — a booking deposit to the facilitator and a treatment deposit passed to the hospital. Each creates its own VAT analysis. A deposit to the facilitator for its arrangement services is advance consideration for the facilitator's 5% supply: account for VAT on receipt.

A treatment deposit the facilitator holds as agent for the hospital is not the facilitator's supply — but only with genuine agency documentation. A deposit the facilitator keeps if the patient cancels needs its own analysis: a forfeited deposit for services never rendered may have a different treatment from a cancellation fee. Draft the patient terms with these distinctions in mind.

Refunds — cancelled treatments, medical inadvisability — adjust the VAT in the period the refund is made. Keep the refund records with the original booking file.

Medical-tourism facilitators spend heavily on overseas marketing — agent commissions, digital advertising targeting source countries, familiarisation trips for referring doctors. These are deductible business expenses with invoices and contracts, and they are often the business's largest cost line.

Commission payments to overseas referring agents need particular care: written agency agreements, commission statements tied to converted patients, and proof of payment. Undocumented "referral fees" are routinely disallowed — and in healthcare, undocumented referral payments attract regulatory scrutiny beyond tax.

VAT on overseas marketing services may trigger the reverse charge where the services are used in the UAE — map the marketing vendors like any other imported service.

The UAE's coming e-invoicing regime will cover the facilitator's B2B invoicing — commissions to and from hospitals, agent settlements — and preparation should start now: verified TRNs for hospital and agent counterparties, booking-referenced invoices, and sequential numbering.

The patient-facing side needs equal attention: treatment package invoices that separate the facilitator's commission from the treatment consideration, with the CD 149/2026 caveat carried on the invoice until the FTA clarifies. When clarification arrives, the invoice template must change the same day as the price lists.

Multi-currency billing — patients paying in source-country currencies — needs the AED conversion documented per invoice at the correct rate. Build the FX logic into the billing system, not into spreadsheets.

A VAT regime transition — which CD 149/2026 is — is the highest-risk period for errors: old treatments applied after the effective date, new treatments applied before clarification, package prices mixing the two. Quarterly self-reviews during the transition are essential.

Reconcile patient billings to VAT returns, check that the treatment-VAT position applied matches the current published position, and correct errors through EmaraTax voluntary disclosure promptly. In a transition, the FTA expects businesses to be actively managing the change — a documented transition plan is evidence of reasonable care (a general compliance point, not a published FTA instruction on CD 149/2026).

Keep a CD 149/2026 file: the decision text, FTA clarifications as published, the position taken per period, and the advice relied on. In an audit, this file is the difference between an error and negligence.

A facilitator's tax position is written in its hospital agreements — and the agreements need tax-aware drafting. The commission or mark-up mechanics (percentage of treatment value? fixed fee per patient? tiered by volume?) determine the facilitator's consideration and therefore its VAT base. Payment terms (on patient admission? on discharge? on collection?) set the tax points. Exclusivity or preferred-partner status has value that should be priced or documented. Read every hospital agreement as a VAT document: the commercial terms are the tax terms.

Liability allocation matters commercially and evidentially: who is responsible if treatment goes wrong, who handles patient complaints, who refunds what. The liability clauses evidence the agency-vs-principal position — a facilitator that contractually guarantees the treatment outcome looks less like an agent. Align the liability position with the intended VAT model; contradictory contracts (agent for VAT, principal for liability) are the worst of both worlds.

Data-sharing between facilitator and hospital — patient records, treatment plans, outcomes — needs data-protection compliance alongside the commercial terms. The data flows also evidence the service geography for VAT: document where the patient data is processed and by whom.

Finally, build the CD 149/2026 review into the agreement cycle: hospital contracts should include a clause addressing VAT-treatment changes on the medical component, so a clarification does not trigger a renegotiation under pressure. Agreements renewed annually should be reviewed annually — the tax position is only as current as the contract.